Researchers at the Leiden University Medical Center have identified specific genetic variants that may contribute to exceptional longevity and a prolonged healthspan. By analyzing the genomes of long-lived families, the team isolated 12 rare protein-altering genetic variants, including a mutation in the CGAS gene, which appears to influence how the body manages inflammation and cellular repair. These findings, presented at the European Society of Human Genetics conference, offer new insights into the biological mechanisms that delay the onset of chronic, age-related diseases.
How Family Studies Reveal Longevity Secrets
Studying families provides a unique window into the mechanics of aging because it helps researchers differentiate between lifestyle influences and inherited biological advantages. According to data from the Leiden Longevity Study, individuals with long-lived parents tend to experience a significantly delayed onset of cardiometabolic diseases. Specifically, these individuals develop conditions like heart disease or diabetes an average of 13 years later than those whose parents had average lifespans. By focusing on sibships—groups of siblings with the same parents—researchers can more effectively narrow down genetic markers that are shared among family members who remain healthy into their 80s and 90s.
The Role of the CGAS Gene in Healthy Aging
One of the most significant findings involves the CGAS (cyclic GMP-AMP synthase) gene, which plays a central role in the body’s inflammatory response. When cells are damaged or infected, CGAS typically triggers inflammation to help the body clear the threat. However, excessive or chronic inflammation is a known driver of aging and tissue degradation. Researchers hypothesize that the identified genetic variant may result in a more moderate inflammatory response. This reduced activity allows the body to clear infections and repair damage effectively without the long-term, systemic damage associated with chronic, low-grade inflammation.
Why Genetic Research Requires In Vivo Models
Identifying a genetic variant is only the first step in understanding its impact on human health. Because the CGAS pathway is essential for immune defense, completely inhibiting it could leave an individual vulnerable to severe infections. To determine how this specific mutation functions in a living system, scientists are transitioning to animal models. According to the research team at Leiden, they plan to introduce the CGAS mutation into killifish, which are commonly used in aging research due to their naturally short lifespans of three to nine months. These studies will help determine if the mutation directly extends survival and protects tissues from age-related decline in a controlled environment.
Key Factors Influencing Healthspan
While genetics play a critical role, they are only one part of the equation for healthy aging. The following table summarizes the primary factors that researchers distinguish when studying why some individuals remain free of chronic illness longer than others:
| Factor | Description |
|---|---|
| Genetics | Inherited variants, such as those in the CGAS pathway, that regulate inflammation and cellular maintenance. |
| Socioeconomic Status | Access to resources, education, and healthcare that influence long-term health outcomes. |
| Lifestyle & Behavior | Diet, physical activity, and stress management, which interact with genetic predispositions. |
| Environmental Exposure | External factors like pollution or chemical exposure that impact cellular health over time. |
Future Directions for Longevity Research
The goal of this research is not merely to extend the human lifespan, but to increase the “healthspan”—the number of years a person lives in good health, free from cognitive decline and chronic disease. By shifting the focus from individual long-lived people to entire families, scientists can better isolate rare, high-impact mutations. As this work continues, collaborations between international research institutions, including those at the Max Planck Institute for the Biology of Ageing, will be essential to validate these candidate genes and eventually identify potential therapeutic targets for age-related health conditions.
Related reading